Innovative Medical Technologies L C is categorized under Medical Research in Houston, TX and active since 1999.
Innovative Medical Technologies L C was established in 1999, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact George Bretz at the company’s single location by writing to 2411 Ftn View Drive # 200, Houston, Texas TX 77057 or by phoning (713) 458-4600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Innovative Medical Technologies L C |
| Contact Person: | George Bretz |
| Address: | 2411 Ftn View Drive # 200, Houston, Texas 77057 |
| Phone Number: | (713) 458-4600 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Innovative Medical Technologies L C was started in 1999 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact George Bretz for inquiries that concern Innovative Medical Technologies L C by calling the company number (713) 458-4600, as your correspondence is most welcome. Additionally, the physical location of the single location of Innovative Medical Technologies L C can be found at the coordinates as well as the street address 2411 Ftn View Drive # 200 in Houston, Texas 77057.
For its online presence, you may visit Innovative Medical Technologies L C’s website at and engage with its social media outlets through on Twitter and on Facebook.